Related Experiment Video
Updated: Mar 17, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Tumor Microenvironmental Stimuli-Responsive Linear-Dendritic Polymeric Conjugate as Potential Nanomedicine
Yongchao Wang1, Pan Xiang1, Yinggang Li1
1Department of Radiology, Institution of Radiology and Medical Imaging, Huaxi MR Research Center (HMRRC), Department of Thoracic Surgery and Institute of Thoracic Oncology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
A novel linear-dendritic polymer nanoparticle effectively delivers doxorubicin (DOX) for cancer therapy. This tumor-responsive nanomedicine enhances drug accumulation at tumor sites while reducing side effects.
Area of Science:
- Polymer Chemistry
- Nanomedicine
- Drug Delivery Systems
Background:
- Developing advanced drug delivery systems is crucial for effective cancer therapy.
- Tumor microenvironment-responsive materials offer targeted drug release, minimizing systemic toxicity.
- Linear-dendritic polymers present unique architectures for nanocarrier design.
Purpose of the Study:
- To synthesize and characterize a tumor microenvironment-responsive, linear-dendritic polymer-doxorubicin conjugate.
- To evaluate the self-assembly, drug release kinetics, and in vitro/in vivo anticancer efficacy of the developed nanomedicine.
- To assess the safety profile of the nanomedicine in a preclinical cancer model.
Main Methods:
- Two-step reversible addition-fragmentation chain transfer (RAFT) polymerization was employed to synthesize the poly[N-(2-hydroxypropyl) methacrylamide] (polyHPMA)-based copolymer-doxorubicin conjugate (pHPMA-block-pDendron-DOX).
- The conjugate self-assembled into nanoparticles (NPs) incorporating a tumor-cleavable Gly-Phe-Leu-Gly (GFLG) peptide and a pH-sensitive hydrazone bond.
- In vitro cytotoxicity assays using 4T1 cells and in vivo studies in a 4T1 murine breast cancer xenograft model were conducted.
Main Results:
- The synthesized pHPMA-block-pDendron-DOX conjugate formed stable nanoparticles that exhibited cathepsin B- and pH-responsive drug release.
- Internalization via endocytosis pathways led to significant cytotoxic effects on 4T1 cancer cells.
- Enhanced doxorubicin accumulation at the tumor site and promising anti-cancer effects were observed in vivo, with significantly reduced side effects.
Conclusions:
- The linear-dendritic polymer conjugate successfully self-assembled into a tumor-responsive nanomedicine for targeted doxorubicin delivery.
- The developed nanomedicine demonstrated potent anticancer activity and an improved safety profile, highlighting its potential as an efficient and safe therapeutic agent.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
The Tumor Microenvironment
The Tumor Microenvironment
Modified-Release Drug Delivery Systems: Site-Targeted
Tumor Immunotherapy

